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Abstract 
A recent investigation in the architecture and chemical composition of amyloid- (A) plaques in ex 
vivo histological sections of an A-overexpressing transgenic mouse hippocampus, has shed light 
onto the infrared light signature of cell-activation related biomarkers of Alzheimer’s disease. A 
correlation was highlighted between the biomechanical properties detected by Brillouin microscopy 
and the molecular make-up of A plaques provided by FTIR spectroscopic imaging and Raman 
microscopy (with correlative immunofluorescence imaging) in this animal model of the disease. In 
Brillouin spectra of heterogeneous materials such as biomedical samples, peaks are likely the result 
from multiple contributions, more or less overlaid on a spatial and spectral scale. The ability to 
disentangle these contributions is very important as it may give access to discrete components that 
would otherwise be buried within the Brillouin peak envelope. Here, we applied an unsupervised 
non-negative matrix factorization method to analyse spontaneous Brillouin microscopy maps of A 
plaques in transgenic mouse hippocampal sections. The method has already proven successful in 
decomposing chemical images and is applied here for the first time to acoustic maps acquired with a 
Fabry-Perot Brillouin microscope. We extracted and visualised a decrease in tissue rigidity from the 
core through to the periphery of the plaque, with spatially distinct components that we assigned to 
specific entities. This work demonstrates that it is possible to reveal the structure and mechanical 
properties of A plaques, with details visualized by the projection of the mechanical contrast into a 
few relevant channels. 
 
 
Introduction 
 
Dementia is a very prevalent disease, which affects around 47 million people worldwide, a number 
that is predicted to triplicate by 2050 based on current trends due to an ageing population.1 
Amyloidopathy is a major hallmark of Alzheimer’s disease (the most common form of dementia) and 
consists of abnormal deposits of the amyloid- (A) peptide in the brain parenchyma. 
 
There is no reliable and affordable diagnostic tool for Alzheimer’s in vivo. This has prompted early 
applications of vibrational spectroscopy and imaging techniques to investigate the structure and 
molecular constituents of Aβ plaques in the brain of both humans and mouse models of the 
disease.2, 3 These studies have revealed the presence in many plaques of a lipid-rich layer 
surrounding the core that is made of intermolecular β-sheet structures of the Aβ peptide. We 
clarified the origin of this lipid layer in senile plaques within ex vivo hippocampal sections of Aβ-
overexpressing TASTPM mouse brain (a model for familial Alzheimer’s disease) using a combination 
of chemical imaging (FTIR spectroscopic imaging and Raman microscopy) and immunofluorescence.4 
The lipid layer stained positive for astrocytes co-localized with the lipid-loaded ring. This was an 
important result as it shows that FTIR and Raman techniques not only are sensitive to Aβ peptide 
structure and aggregation, but they can also detect signatures of astrogliosis and potentially other 
biomarkers of inflammation with potential for clinical translation. 
 
Brillouin spectroscopy is an emerging biophotonic technique, which probes micromechanical 
properties of matter through the frequency shift of light scattered off thermally induced acoustic 
waves or phonons at high frequency (GHz). It is an optical, contactless and non-destructive 
technique, and probes native signals that relate to the viscoelasticity or stiffness of matter on a 
micro-scale. Typically a Brillouin spectrum contains one or more sets of symmetric inelastic 
scattering peaks to the central Rayleigh line; these peaks arise from Doppler-shifted longitudinal 
phonons propagating with a frequency equal to the Brillouin shift.5 We applied Brillouin microscopy 
to a range of biological and medical samples including protein fibres,6-8 biofilms,9, 10 live cells,11 
normal tissues6 and pathologies including pre-cancerous stages in epithelial tissue12, 13 and Aβ 
plaques in Alzheimer’s brain.14 We found important correlations between chemical composition, 
structure and micromechanics, which form the basis for further investigations on living systems and 
translation to the clinics. For the first time, the micromechanical properties of the lipid membrane in 
astrocyte processes surrounding Aβ plaque cores in ex vivo sections of transgenic mouse 
hippocampus, were characterised using Brillouin scattering.14 
 
As for other spectroscopic techniques, the Brillouin peak has two major contributions to the 
observed linewidth: homogeneous broadening (due to local viscosity affecting each mode 
identically) and heterogeneous broadening (arising from mechanically heterogeneous 
‘environments’ within the scattering volume). Multiple-scattering processes in turbid media may 
also result in effective broadening. However, due to the few micrometre interaction length below 
the sample surface in the confocal Brillouin scattering setup used, multiple scattering can be 
neglected for the data presented. Additionally, asymmetric broadening is generated by the finite 
numerical aperture of collection of scattered light. In the present data this effect is small (~1%) due 
to the small NA of the objective used, and thus does not provide a significant broadening.14 The 
heterogeneous character of line broadening in Brillouin spectra is an issue that insofar has been 
solved only in the case of sufficiently separated contributions such as those from live cell and the 
buffer saline.11 For biomedical applications, this is a particularly pressing issue. In Aβ plaques for 
which we have demonstrated the mechanical heterogeneity in a mouse model of amyloidopathy,4 
this is apparent as the Brillouin peak detected in a mapping mode from any spatial location at low 
magnification (20X) arise from multiple contributions from different molecular constituents. An in-
depth investigation of the molecular species involved in the mechanism of Aβ plaque formation is 
the first step to unravel the pathophysiology of this complex disease. 
 
The aim of this work was to investigate whether it is possible to separate multiple phonon modes 
contributing to the spectral band shape of the Brillouin peak in a heterogeneous sample. We used an 
Aβ-overexpressing transgenic mouse model of Alzheimer’s disease, the TASTPM mice that carry a 
double mutation on the amyloid precursor protein (APP) and one single mutation on the presenilin-1 
gene causing prevalent amyloid plaque deposition before it is six month old.15, 16 Aβ deposits within 
histological sections of fixed brain hippocampus from TASTPM mice were analysed. In this work, we 
tested a new method based on non-negative matrix factorization (NMF)17, 18 to decompose Brillouin 
hyperspectral datasets of Aβ plaques in transgenic mice hippocampus. In this method, the 
hyperspectral images are interpreted as a linear combination of a limited number of components, 
each characterised by a spectrum and a concentration map. Both spectra and spatial maps have a 
non-negativity constrain, hence the basis is not orthonormal. The algorithm searches for the set of 
spectra and spatial distributions which minimise the factorization error. Here we provide evidence 
that distinct spatial locations within Aβ plaques – which correspond to specific molecular species – 
have differential viscoelastic properties probed by Brillouin spectroscopy. This opens up new 
avenues for data analysis of micro-Brillouin images based on chemometrics and multivariate 
statistics. 
 
 
Results 
 
Figure 1 shows bright-field reflection and Brillouin images of amyloid plaques in transgenic mouse 
brain sections, whereby the plaque core is easily recognizable from the elevated frequency of the 
Brillouin peak. This has previously been shown to correspond to intermolecular β-sheets of 
aggregated Aβ peptide detected by FTIR and Raman spectroscopy applied to the same tissue 
sections.4 
 
 
Figure 1. (Top panel) Reflection optical images of plaques in transgenic mouse brain sections containing the hippocampus. 
Yellow boxes indicate the 66×60 m2 (left) and 50×43 m2 (right) areas of the Brillouin map of (a) a whole plaque and (b) a 
quarter of a plaque. (Middle and bottom panels) Brillouin images refer to the distribution of (b, e) frequency shift and (c, f) 
linewidth derived from DHO fit analysis applied to the Brillouin peak across the map spectra (see Methods). 
 
Indeed, the elevated rigidity of the plaque core observed here can be attributed to the deposition of 
aggregates of β-amyloid protein in β-pleated sheet conformation and to the exclusion of hydration 
water from this highly hydrophobic region.14 A lipid-rich layer surrounding the plaque core was 
apparent in the chemical images as well as in the mechanical maps through a depleted frequency 
shift (Figure 1b and e) and an increased linewidth (Figure 1c and f) of the Brillouin peak. 
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Moving on to the factorization analysis, we note that the only supervised parameter we have to 
choose is the number of components used. It was chosen here to result in a spectral error without 
obvious remaining spatial structure (see Fig. 2, which refers to the map of a whole plaque – Fig. 1a). 
 
 
Figure 2. Factorization error of the NMF analysis applied to the map of a whole plaque (Fig. 1a) as function of the number 
of components N used. Spatially resolved error maps for N=2 to 6 on a greyscale as shown, and the global error, are given. 
 
The spectral error at each position is defined as the root-mean-square of the error over the spectral 
points normalized by the Frobenius norm of the measured data over these points.17 For 2 and 3 
components, the spectral error shows significant spatial structures, both at the core and at the edge 
of the plaque, indicating that there are too few components to describe the data within its noise. 
Using 4 or more components, no clear spatial structure in the error is observed. Furthermore, the 
global error, defined as the ratio of the Frobenius norms of the error and the data over all data, 
decreases with increasing number of components (see Fig. 2), and shows a significantly lower 
decrease adding a fifth component compared to adding the third or fourth component. Moreover, 
when using more than 4 components, the factorization returns pairs of components which have 
similar spatial distributions, indicating that the algorithm is splitting a physically meaningful 
component into two. We therefore use in the following 4 components, for which the results of the 
unsupervised decomposition method are reported in Figure 3 and 4. 
 
 Figure 3. (Top panel) Reflection optical image of a plaque in a transgenic mouse brain section and factorisation basis 
spectra retrieved by NMF. (a) Photomicrograph of the plaque with yellow box denoting the region of the Brillouin map. (b) 
Spectra of the four factorisation components. Symbols denote the data and lines indicate the DHO fit result. The 
components are colour coded so that (middle and bottom panels) the corresponding concentration maps are also 
presented. The four components can be attributed (see text) to the distribution of (c) the plaque core made of β-sheet 
structures, presenting a spectrum with the largest frequency shift, (d) a first intermediate region, (e) a second 
intermediate, more diffuse region, and (f) the periphery of the plaque having a broad linewidth and small frequency shift, 
plausibly related to the lipid-rich region of the astrocyte processes. The greyscale of the concentration maps goes from 0 
(black) to 1 (white). The map corresponds to a 66×60 m2 area of the specimen acquired with a step size of 1.5 m. 
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 Figure 4. (Top panel) Reflection optical image of a quarter of a plaque in a transgenic mouse brain section and factorisation 
basis spectra retrieved by NMF. (a) Photomicrographs of the plaque with yellow box denoting the region of the Brillouin 
map. (b) Spectra of the four factorisation components. Symbols denote the data and lines indicate the DHO fit result. The 
components are colour coded so that (middle and bottom panels) the corresponding concentration maps are also 
presented. The four components can be attributed (see text) to the distribution of (c) the plaque core made of β-sheet 
structures, presenting a spectrum with the largest frequency shift, (d) a first intermediate region, (e) a second 
intermediate, more diffuse region, and (f) the periphery of the plaque having a broad linewidth and small frequency shift, 
plausibly related to the lipid-rich region of the astrocyte processes. The greyscale of the concentration maps goes from 0 
(black) to 1 (white). The map corresponds to a 50×43 m2 area of the specimen acquired with a step size of 1.5 m. 
 
 
The linewidths of the components resolved by the factorization analysis are less than 5 GHz (see 
below), hence they are smaller to the linewidths previously obtained by fitting each spectrum of the 
maps to a single damped harmonic oscillator (DHO) function (Figure 1c and f). This suggests that the 
partially heterogeneous nature of the Brillouin peaks can be resolved by the hyperspectral analysis, 
giving a reasonable proxy for the different biological components of the tissue. 
 
When comparing these results with those from analogous decomposition of vibrational 
spectroscopic images (e.g. from IR and Raman microscopy techniques), we must note that Brillouin 
microscopy cannot access detailed molecular level information since it reveals collective excitations 
(acoustic phonons) with frequency and linewidth given by average mechanical properties over 
micrometric mean free paths. However, heterogeneity in biological matter is expressed at various 
length scales, and it is invaluable to be able to resolve mechanical heterogeneities on a micrometre 
scale within the scattering volume. The unsupervised factorization method applied here is the first 
step in this direction, as demonstrated by these results, which are consistent with the biochemical 
composition of the plaques in terms of lineshape and intensity distribution of the components. 
 
For each of the two spectral datasets (Figure 3 and 4), the lineshape of the four components was 
fitted to a homogeneous model, described by a DHO function; results in terms of peak position and 
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linewidth are shown in Figure 5. It can be seen that, in all cases, the homogeneous model gives a 
reasonably good fit. The quality of the fit deteriorates for components with spectra peaked at 
smaller frequencies, i.e. component 4. We attribute this disagreement to a partial heterogeneous 
broadening of the spectra which is not separated into different components by NMF. This indicates 
that the spatial maps do not show sufficient regions of the corresponding homogeneous 
constituents. Such limitations could be overcome if, within the NMF algorithm, the component 
spectra would be constrained to DHO model shapes, which is a promising avenue for future 
development of the algorithm. 
 
With regards to the assignment of the concentration images (greyscale images in Figure 3 and 4), a 
comparison with the biological composition of the tissue suggests that: 
 
• Component 1 (Figure 3c and 4c), the component with the largest frequency shift, 
corresponding to the largest stiffness, is essentially consistent with the plaque core, made of 
aggregated Aβ peptide, a hydrophobic region from which water is excluded. The rigidity of 
this region can be explained in terms of mechanical properties of dense core plaques. 
 
• Component 2 (Figure 3d and 4d) is mainly distributed around the core, in close proximity but 
yet in a complementary (spatially distinct) area. This can be identified as a transition region, 
plausibly including α-helical structures of the Aβ peptide, with different levels of 
aggregation, which form the interfacial region between the largely hydrophobic plaque core 
and the hydrophilic extracellular matrix (ECM) compartment. It is expected that the physical 
properties of the tissue are such that there is a gradient in solubility from the dense-core Aβ 
deposits towards the outer normal tissue. 
 
• Component 3 (Figure 3e and 4e) extends towards the outer layers of the plaque, hence it 
seems appropriate to identify it with the average elastic properties of the normal tissue 
(ECM). Its distribution denotes a second layer around the plaque core. Note that the 
scattering intensity gradually decreases from the core through to the periphery of the 
plaque owing to a decrease in thickness and/or density of the tissue. 
 
• Component 4 (Figure 3f and 4f) is the softest one, and is mainly localized in the region of the 
lipid ring,4, 14 where elevated (phospho)lipid signal has been associated with astrocyte 
processes (i.e. membrane extensions) radially projecting towards the plaque core. This is the 
component with the largest linewidth, suggesting pronounced viscoelastic effects. This 
component can be attributed to the astrocytes and, given that the plasma membrane of 
astrocytes is mainly formed by lipids in these dry tissues, the stiffness measured here may 
essentially correspond to that of the lipid membrane hence providing a qualitative measure 
of the cell membrane’s GHz mechanical properties. 
 
Dispersion and absorption associated to the four components can be better seen in Figure 5. A 
progressive reduction in frequency associated with an increase in linewidth is observed for the four 
components from #1 to #4, and this is consistent for the two plaques (red-to-blue symbols). 
 
 Figure 5. Plot of (top part) the frequency shift and (bottom part) linewidth of the four components derived from NMF 
applied to the Brillouin maps of Aβ plaques in ex vivo sections of transgenic mouse hippocampus. Symbols are colour 
coded according to the components as shown in figure 3 and 4. The components were fitted to a DHO function and the 
resulting frequency and linewidth are shown. 
 
 
This plot reproduces the distinctive gradual change in physical properties going from the dense core 
through to the periphery of the plaque. A gradient of frequency shift and linewidth can be 
interpreted based on the distinctive structure of Aβ deposits whereby hydrophobic and hydrophilic 
compartments do cross over. The plaque core spectrum has a narrow peak around 18 GHz, whilst 
the intermediate regions show larger linewidths and depleted frequencies, and the astrocyte region 
has a linewidth that is approximately twice as large as the core and a frequency that is reduced by a 
quarter. From the frequency shift, the longitudinal elastic modulus at GHz frequency can be 
derived.19 This requires that density and refractive index of the medium are known; generally an 
approximation is applied in that the ratio /n2 is fairly constant far from electronic resonances.14 
Here, by taking n = 1.3620 and  ~ 1.0 g/cm3 and considering a 1% frequency shift due to the finite 
NA of the objective used, we obtained the elastic modulus for the distinct components of the plaque 
as being approximately 12 GPa (#1), 10 GPa (#2), 9 GPa (#3), and 8 GPa (#4). These trends suggest 
that the decrease in measured stiffness across the different components can also be promoted by a 
viscoelastic effect, i.e. a reduction of the relaxation time of molecular motions21 going from the core 
through to the periphery of the plaque.  
 
 
Discussion 
 
Micro-Brillouin spectroscopy was used to characterize the micromechanics of hippocampal amyloid 
plaques in Aβ-overexpressing transgenic mice. The composition of such plaques is known to be rich 
in intermolecular -sheet structures of the A peptide and dense-core plaques have a distinctive 
‘halo’ encompassing the core that is formed by activated astrocyte processes.4 The change in 
mechanical properties across the A deposits can be explained by a parallel change in the pattern of 
molecular species into the brain.14 Mice of two groups, transgenic (TASTPM) and normal control 
animals, were studied. A previous in situ examination of the same hippocampi has shown enhanced 
protein’s IR absorbance and Raman scattering, indicating that plaques occurred in the TASTPM 
group.4 This was corroborated by correlative immunofluorescence imaging of the same hippocampi 
stained with amylo-glo. An important finding supported by medical literature22 was the detection of 
enhanced lipid signal in the region surrounding the plaque core that was attributed to astrocyte 
processes with the use of immunohistochemical techniques. Astrocytic activation associated with A 
plaques has been known for some time, however this was the first demonstration that chemical 
imaging techniques can detect not only plaques but also associated astrogliosis, which might have a 
protective role limiting the development of amyloidosis-dependent cognitive decline.23 
Brillouin microscopy and correlative micro-Raman analysis confirmed the heterogeneity in A 
deposits through maps of Brillouin frequency shift (related to stiffness) and linewidth (related to 
apparent viscosity), which indicated that plaques have a rigid core rich in A protein with -pleated 
sheet conformation, a viscoelastic lipid-rich layer surrounding the core, and an heterogeneous 
extracellular matrix plausibly disseminated of glial cell bodies.14 For these reasons, this 
micromechanical method may provide an additional contrast mechanism to detect amyloidopathy. 
 
Here we used a new method based on non-negative matrix factorization (NMF)17 to decompose 
Brillouin hyperspectral datasets of A plaques in the hippocampus of an Aβ-overexpressing 
transgenic mouse. In this method, the hyperspectral images are interpreted as a linear combination 
of a limited number of components, each characterised by a spectrum and a concentration map. We 
used as many components as required to describe most of the variance in the dataset, leaving only a 
randomly distributed factorisation error. We found that distinct spatial locations within Aβ plaques – 
which correspond to specific molecular species – have differential viscoelastic properties probed by 
Brillouin spectroscopy. Four components were required to describe the data, each characterised by 
a spectrum with frequency and linewidth that change progressively when going from the core 
through to the periphery of the plaque. Component 1, the one with the largest rigidity, corresponds 
to the dense core made of aggregated Aβ peptide; component 2 can be identified as a transition 
region, plausibly including α-helical structures of the Aβ peptide with different levels of aggregation; 
component 3, which extends towards the outer layers of the plaque, can be assigned to the normal 
tissue’s ECM; component 4 is the softest one and is mainly consistent with the lipid-rich layer14 
previously associated with astrocyte processes.4 Given that the plasma membrane of astrocytes is 
mainly formed by lipids in these dry tissues, the stiffness measured here may essentially correspond 
to that of the lipid membrane hence providing a qualitative measure of cell membrane’s stiffness. 
Both components 1 and 2 are essentially homogenous components with some damping, the others 
(3 and 4) have some inhomogeneity in stiffness which reflects a distribution in material’s 
parameters. 
 
This is an important result because distinct components of plaques may be obscured by overlapping 
spectral contributions, whilst the multivariate method that analyse both spectral and spatial 
distribution within a hyperspectral dataset can retrieve the constituent components. The result may 
have clinical implications. In fact, the mechanical properties of the plaques may influence the 
interaction between the biologically active, soluble components of the plaque (Aβ monomers, 
oligomers, protofibrils and fibrils) and the surrounding tissues and cell types, including neurons, 
astrocytes, microglia and endocytes. This, in turn, may affect how the disease progresses. In 
addition, newly developed Aβ scavenging drugs, aim at treating AD by removing pathogenic amyloid 
species from the brain parenchyma. Recent clinical trials of these compounds resulted in major 
setbacks,24, 25 pushing the AD research community to reconsider the approach towards 
amyloidopathy, highlighting the need to better describe Aβ plaque complex chemistry and physical 
properties. Our approach, aiming at correlatively describing the physical and chemical properties of 
the plaques, may have a critical role in informing the development of novel Aβ scavenger 
compounds and the assessment of their efficacy. 
 
It is noteworthy that the finite number of components used in the factorization method gives a 
coarse grained picture of the otherwise gradually varying properties of the tissue, so that e.g. 
Component 2 reflects average properties of the transition region. Also, the method applied here 
makes no assumption on the lineshape of the single components; in a further implementation of the 
algorithm, the single spectra could be constrained to a viscoelastic model such as DHO and a set of 
homogeneous components could be retrieved. We emphasize that NMF extracts components and 
their spatial concentrations in a global analysis, which is specifically useful if the material 
investigated consists of a mixture of a few components. It also allows to describe inhomogeneous 
distributions within the focal volume, which create overlapping modes. In the traditional pixel-wise 
fitting of the spectra with a DHO model, such a distribution of viscoelastic properties will return an 
average frequency, and an overestimated broadening. Using multiple DHO components in such a fit 
is possible, but tends to be unstable. Since the NMF analysis uses all spectra in the dataset at the 
same time to extract the components and spectra, it is robust in dealing with multiple components. 
This is the first time that a multivariate statistical model was applied to Brillouin microscopy images 
to decompose the hyperspectral datasets in multiple distinct components. 
 
In these measurements, the noise is simply the square root of the intensity, and the signal-to-noise 
ratio is considerably better than that typically obtained with VIPA spectrometers, due to the high 
luminosity of the FP interferometer9 and the adopted integration time. Whilst we have 
demonstrated that recent developments in scanning FP interferometer enable sub-second time 
resolution,9 here we investigated fixed samples and chose to have a very good signal-to-noise ratio 
to enable a detailed spectral bandshape analysis. Multivariate statistics can be used to analyse 
hyperspectral datasets acquired at lower signal-to-noise ratio (hence faster acquisitions) and with 
suitably numerous datapoints. In this sense, even maps with larger point-to-point intervals can be 
exploited, hence speeding up the analysis. This has been shown using a combination of NMF and 
sparse sampling for CARS microscopy,26, 27 and could be used also for Brillouin spectroscopy to allow 
for high speed mapping. 
 
In summary, the results demonstrate the potential of Brillouin micro-spectroscopy for studying 
Alzheimer’s disease. Specifically here, we have shown the application of multivariate analysis, which 
allowed the decomposition of the highly overlapped features forming the Brillouin spectrum of such 
complex specimens, and hence the recognition of different constituents. The results of NMF 
demonstrated structural motifs of the amyloid plaques that are difficult to separate via univariate 
analysis. In particular, NMF provided evidence of individual components of the tissues such as the 
dense core made of aggregated -sheets of A peptide, transition regions plausibly characterised by 
-helical structures and normal tissue, and astrocyte processes as the outermost layer. Thus, by 
taking into account spatial correlations among spectral features, multivariate analysis was able to 
discriminate between different components of the hippocampal CA1 region, while a univariate 
approach showed limitations. This demonstrated that the application of chemometric techniques 
allows information to be obtained from mechanically specific datasets, such as those measured by 
Brillouin micro-spectroscopy. Since the Brillouin spectroscopy does not involve physical contact with, 
and hence no mechanical interference with, the specimen, it is ideally suited to human in vivo 
applications and, as it relies upon propagation of longitudinal acoustic waves, it enables applications 
to tissues at-depth. Brillouin microscopy with multivariate data analysis could evolve into an 
important tool for routine diagnosis of Alzheimer’s disease if suitable in vivo probes become 
available. Analysis of the micromechanics of plaques might, for example, allow identification of 
those likely to be ‘protected’ by astrogliosis and not cause clinical events. 
 
 
Methods 
 
Sample preparation. Animal procedures complied with the UK Home Office Guidelines and the 
University of Exeter Animal Welfare Ethical Review Board. Male 12 months old Aβ-overexpressing 
TASTPM (transgenic, TG) mice were used in this study. TASTPM mice carry two mutations on the APP 
gene (APPSwe K670N, M671L) and one on the presenilin 1 gene (M146V) that can be found in patients 
affected by familial Alzheimer’s disease 15, 16. Animals were housed at room temperature under a 12 
hour light cycle, and fed a normal diet with free access to food and water ad libitum before being 
sacrificed 28. 
Tissues were collected and sectioned as previously described 4, 28 before being mounted on Raman-
grade polished calcium fluoride slides (Crystran, Poole, Dorset, UK). Two plaques within a brain 
hippocampal section of TASTPM mouse were analysed, and two microspectroscopic maps were 
obtained. 
 
Brillouin microscopy. Brillouin micro-spectroscopy maps were collected with a customized JRS 
Scientific Instruments CM-1 confocal microscope equipped with a 532 nm laser and a Mitutoyo long 
working distance 20⨉ (NA 0.42) objective. The backscattered light from the sample was dispersed 
through a (3+3)-pass Fabry-Perot interferometer onto a single photon avalanche photodiode 
detector.9 The spectral resolution was approximately 100 MHz. Characteristic Brillouin peaks due to 
longitudinal acoustic wave propagation in the tissue were analysed, yielding maps with a spatial 
resolution in the range of 2 μm for the lateral and 8 μm for the axial dimension. These peaks are a 
proxy for viscoelasticity of amyloid plaques.14 Brillouin maps were acquired in raster scanning mode 
with an exposure time of 90 s per point-spectrum and a step size of 1.5 μm, in the range –30 to 30 
GHz, with 5 mW laser power on the sample. GHOST software was used for acquisition and 
manipulation of the data. 
 
Hyperspectral image analysis. For the factorisation analysis, we considered only the anti-Stokes part 
of the hyperspectral images for frequencies larger than ~5 GHz, to suppress contributions from the 
Rayleigh scattering which would affect the analysis. In the case of the whole plaque image, first we 
removed the cosmic rays present in the spectra. Cosmic rays were identified as pixels where the 
intensity exceeded by five times the average intensity of the nearest neighbours. The hyperspectral 
images were then denoised by using a singular value decomposition (SVD) approach.17 In this 
method, noise reduction is achieved by applying SVD on the noise-whitened data and retaining only 
the decomposition components where both the left and right singular values do not show physically 
meaningful spectral and spatial features, respectively. For the plaque images, we considered four 
SVD components. Finally we analysed the denoised hyperspectral data by using NMF with four 
components. The method is unsupervised as random initial guesses for both spectra and 
concentration are used. To improve reproducibility and limit the effect of the randomness of the 
guesses, we employed the knock-out method.18 
 
Fit analysis. The spectra derived from NMF applied to the Brillouin maps were fitted to a damped 
harmonic oscillator (DHO) function,19 arising from a viscoelastic model of homogeneous elastic 
properties. 
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